A meta-analysis demonstrates no significant differences between patient and population preferences

Journal of Clinical Epidemiology

Volumn 59, Issue 7, 2006, Pages 653-664

  Dolders, Maria G T ^a,d   Zeegers, Maurice P A ^b,c   Groot, Wim ^a   Ament, André ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Health policy; Health state; Meta analysis; Patient preferences; Population preferences; Resource allocation

Indexed keywords

AGE DISTRIBUTION; CONFIDENCE INTERVAL; DATA ANALYSIS; DATA EXTRACTION; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HEALTH STATUS; HUMAN; INFORMATION PROCESSING; MEDICAL ASSESSMENT; MEDICAL INFORMATION; MEDICAL LITERATURE; PATIENT ASSESSMENT; PATIENT CARE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUALITY ADJUSTED LIFE YEAR; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; RESOURCE ALLOCATION; REVIEW; SELF EVALUATION; SENSITIVITY ANALYSIS; SEX DIFFERENCE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; WELLBEING;

CONSUMER SATISFACTION; HEALTH STATUS; HUMANS; PATIENT SATISFACTION; RESOURCE ALLOCATION; STATISTICS, NONPARAMETRIC;

EID: 33744775948     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2005.07.020     Document Type: Review

References (118)

1. Drummond M., Torrance G., and Mason J. Cost-effectiveness league tables: more harm than good?. Soc Sci Med 37 (1993) 33-40
2. Gerard K., and Mooney G. QALY league tables: handle with care. Health Econ 2 (1993) 59-64
3. Mason J., Drummond M., and Torrance G. Some guidelines on the use of cost effectiveness league tables. BMJ 306 (1993) 570-572
4. Ubel P., Loewenstein G., and Jepson C. Whose quality of life? A commentary exploring discrepancies between health state evaluations of patients and the general public. Qual Life Res 12 (2003) 599-607
5. Fryback D.G. Whose quality of life? or Whose decision?. Qual Life Res 12 (2003) 609-610
6. Drummond M.F., O'Brien B.J., Stoddart G.L., and Torrance G.W. Methods for the Economic Evaluation of Health Care Programmes. 2nd ed. (1997), Oxford University Press, Oxford
7. Torrance G.W. Measurement of health state utilities for economic appraisal. J Health Econ 5 (1986) 1-30
8. The EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 16 (1990) 199-208
9. Kaplan R.M., and Anderson J.P. A general health policy model: update and applications. Health Serv Res 23 (1988) 203-235
10. Gold M.R., Siegel J.E., Russell L.B., and Weinstein M.C. Cost-effectiveness in health and medicine (1996), Oxford University Press, New York
11. De Wit G.A., Busschbach J.J., and de Charro F.T. Sensitivity and perspective in the valuation of health status: whose values count?. Health Econ 9 (2000) 109-126
12. Sackett D.L., and Torrance G.W. The utility of different health states as perceived by the general public. J Chronic Dis 31 (1978) 697-704
13. Boyd N.F., Sutherland H.J., Heasman K.Z., Tritchler D.L., and Cummings B.J. Whose utilities for decision analysis?. Med Decis Making 10 (1990) 58-67
14. Balaban D.J., Sagi P.C., Goldfarb N.I., and Nettler S. Weights for scoring the quality of well-being instrument among rheumatoid arthritics. A comparison to general population weights. Med Care 24 (1986) 973-980
15. Froberg D.G., and Kane R.L. Methodology for measuring health-state preferences-III: population and context effects. J Clin Epidemiol 42 (1989) 585-592
16. Froberg D.G., and Kane R.L. Methodology for measuring health-state preferences-II: scaling methods. J Clin Epidemiol 42 (1989) 459-471
17. Ashby J., O'Hanlon M., and Buxton M.J. The time trade-off technique: how do the valuations of breast cancer patients compare to those of other groups?. Qual Life Res 3 (1994) 257-265
18. Tugwell P., Bennett K.J., Sackett D.L., and Haynes R.B. The measurement iterative loop: a framework for the critical appraisal of need, benefits and costs of health interventions. J Chronic Dis 38 (1985) 339-351
19. Egger M., Schneider M., and Davey Smith G. Spurious precision? Meta-analysis of observational studies. BMJ 316 (1998) 140-144
20. Green C., Brazier J., and Deverill M. Valuing health-related quality of life. A review of health state valuation techniques. Pharmacoeconomics 17 (2000) 151-165
21. Nord E. Methods for quality adjustment of life years. Soc Sci Med 34 (1992) 559-569
22. Hurst N.P., Jobanputra P., Hunter M., Lambert M., Lochhead A., and Brown H. Validity of Euroqol-a generic health status instrument-in patients with rheumatoid arthritis. Economic and Health Outcomes Research Group. Br J Rheumatol 33 (1994) 655-662
23. Bartman B.A., Rosen M.J., Bradham D.D., Weisman J., Hochberg M., and Revicki D.A. Relationship between health status and utility measures in older claudicants. Qual Life Res 7 (1998) 67-73
24. Patrick D.L., Ramsey S.D., Spencer A.C., Kinne S., Belza B., and Topolski T.D. Economic evaluation of aquatic exercise for persons with osteoarthritis. Med Care 39 (2001) 413-424
25. Shields R.K., Enloe L.J., and Leo K.C. Health related quality of life in patients with total hip or knee replacement. Arch Phys Med Rehabil 80 (1999) 572-579
26. Wang C., Mayo N.E., and Fortin P.R. The relationship between health related quality of life and disease activity and damage in systemic lupus erythematosus. J Rheumatol 28 (2001) 525-532
27. Sage W.M., Rosenthal M.H., and Silverman J.F. Is intensive care worth it? An assessment of input and outcome for the critically ill. Crit Care Med 14 (1986) 777-782
28. Nicholl C.R., Lincoln N.B., Francis V.M., and Stephan T.F. Assessing quality of life in people with multiple sclerosis. Disabil Rehabil 23 (2001) 597-603
29. Donovan J.L., Kay H.E., Peters T.J., Abrams P., Coast J., Matos Ferreira A., et al. Using the ICSOoL to measure the impact of lower urinary tract symptoms on quality of life: evidence from the ICS-"BPH" Study. International Continence Society-benign prostatic hyperplasia. Br J Urol 80 (1997) 712-721
30. Selai C., and Rosser R. Eliciting EuroQol descriptive data and utility scale values from inpatients. A feasibility study. Pharmacoeconomics 8 (1995) 147-158
31. Lai S.M., and Duncan P.W. Stroke recovery profile and the modified Rankin assessment. Neuroepidemiology 20 (2001) 26-30
32. Merlino L.A., Bagchi I., Taylor T.N., Utrie P., Chrischilles E., Sumner II W., et al. Preference for fractures and other glucocorticoid-associated adverse effects among rheumatoid arthritis patients. Med Decis Making 21 (2001) 122-132
33. Chapman G.B., Elstein A.S., Kuzel T.M., Nadler R.B., Sharifi R., and Bennett C.L. A multi-attribute model of prostate cancer patient's preferences for health states. Qual Life Res 8 (1999) 171-180
34. Cranney A., Coyle D., Pham B.A., Tetroe J., Wells G., Jolly E., et al. The psychometric properties of patient preferences in osteoporosis. J Rheumatol 28 (2001) 132-137
35. Jansen S.J., Stiggelbout A.M., Wakker P.P., Nooij M.A., Noordijk E.M., and Kievit J. Unstable preferences: a shift in valuation or an effect of the elicitation procedure?. Med Decis Making 20 (2000) 62-71
36. Gold M., Franks P., and Erickson P. Assessing the health of the nation. The predictive validity of a preference-based measure and self-rated health. Med Care 34 (1996) 163-177
37. Andresen E.M., Patrick D.L., Carter W.B., and Malmgren J.A. Comparing the performance of health status measures for healthy older adults. J Am Geriatr Soc 43 (1995) 1030-1034
38. Badia X., Roset M., Herdman M., and Kind P. A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states. Med Decis Making 21 (2001) 7-16
39. Devlin N., Hansen P., and Herbison P. Variations in self-reported health status: results from a New Zealand survey. N Z Med J 113 (2000) 517-520
40. Bjork S., and Norinder A. The weighting exercise for the Swedish version of the EuroQol. Health Econ 8 (1999) 117-126
41. Rizzo J.A., and Sindelar J.L. Linking health-related quality-of-life indicators to large national data sets. Pharmacoeconomics 16 (1999) 473-482
42. Hisashige A., Mikasa H., and Katayama T. Description and valuation of health-related quality of life among the general public in Japan by the EuroQol. J Med Invest 45 (1998) 123-129
43. Jenkinson C., Stradling J., and Petersen S. Comparison of three measures of quality of life outcome in the evaluation of continuous positive airways pressure therapy for sleep apnoea. J Sleep Res 6 (1997) 199-204
44. Gudex C., Dolan P., Kind P., and Williams A. Health state valuations from the general public using the visual analogue scale. Qual Life Res 5 (1996) 521-531
45. Elvik R. The validity of using health state indexes in measuring the consequences of traffic injury for public health. Soc Sci Med 40 (1995) 1385-1398
46. Dolan P. Modeling valuations for EuroQol health states. Med Care 35 (1997) 1095-1108
47. Kaplan R.M., Alcaraz J.E., Anderson J.P., and Weisman M. Quality-adjusted life years lost to arthritis: effects of gender, race, and social class. Arthritis Care Res 9 (1996) 473-482
48. Johnson J.A., Coons S.J., Ergo A., and Szava Kovats G. Valuation of EuroQOL (EQ-5D) health states in an adult US sample. Pharmacoeconomics 13 (1998) 421-433
49. Kirsch J., and McGuire A. Establishing health state valuations for disease specific states: an example from heart disease. Health Econ 9 (2000) 149-158
50. Neumann P.J., Kuntz K.M., Leon J., Araki S.S., Hermann R.C., Hsu M.A., et al. Health utilities in Alzheimer's disease: a cross-sectional study of patients and caregivers. Med Care 37 (1999) 27-32
51. Taylor W.J., Lord S., McPherson K.M., and McNaughton H.K. EuroQol EQ-5D may not adequately describe the health of people with disabilities. Disabil Rehabil 23 (2001) 281-285
52. Diaz Prieto A., Gorriz M.T., Badia X., Torrado H., Farrero E., Amador J., et al. Proxy-perceived prior health status and hospital outcome among the critically ill: is there any relationship?. Intensive Care Med 24 (1998) 691-698
53. Kerner D.N., Patterson T.L., Grant I., and Kaplan R.M. Validity of the Quality of Well-Being Scale for patients with Alzheimer's disease. J Aging Health 10 (1998) 44-61
54. Coucill W., Bryan S., Bentham P., Buckley A., and Laight A. EQ-5D in patients with dementia: an investigation of inter-rater agreement. Med Care 39 (2001) 760-771
55. Hollingworth W., Mackenzie R., Todd C.J., and Dixon A.K. Measuring changes in quality of life following magnetic resonance imaging of the knee: SF-36, EuroQol or Rosser index?. Qual Life Res 4 (1995) 325-334
56. Jenkinson C., Stradling J., and Petersen S. Comparison of three measures of quality of life outcome in the evaluation of continuous positive airways pressure therapy for sleep apnoea. J Sleep Res 6 (1997) 199-204
57. Zethraeus N., and Johannesson M. A comparison of patient and social tariff values derived from the time trade-off method. Health Econ 8 (1999) 541-545
58. Polsky D., Wilke R.J., Scott K., Schulman K.A., and Glick H.A. A comparison of scoring weights for the EuroQol derived from patients and the general public. Health Econ 10 (2001) 27-37
59. Hollingworth W., Deyo R.A., Sullivan S.D., Emerson S.S., Gray D.T., and Jarvik J.G. The practicality and validity of directly elicited and SF-36 derived health state preferences in patients with low back pain. Health Econ 11 (2002) 71-85
60. Schackman B.R., Goldie S.J., Freedberg K.A., Losina E., Brazier J., and Weinstein M.C. Comparison of health state utilities using community and patient preference weights derived from a survey of patients with HIV/AIDS. Med Decis Making 22 (2002) 27-38
61. Chen S., Shaheen A., and Garber A. Cost-effectiveness and cost-benefit analysis of using methotrexate vs Goeckerman therapy for psoriasis. A pilot study. Arch Dermatol 134 (1998) 1602-1608
62. Hays R.D., Siu A.L., Keeler E., Marshall G.N., Kaplan R.M., Simmons S., et al. Long-term care residents' preferences for health states on the quality of well-being scale. Med Decis Making 16 (1996) 254-261
63. Trippoli S., Vaiani M., Lucioni C., and Messori A. Quality of life and utility in patients with non-small cell lung cancer. Quality-of-life Study Group of the Master 2 Project in Pharmacoeconomics. Pharmacoeconomics 19 (2001) 855-863
64. Lalonde L., Clarke A.E., Joseph L., and Grover S.A. Conventional and chained standard gambles in the assessment of coronary heart disease prevention and treatment. Canadian Collaborative Cardiac Assessment Group. Med Decis Making 19 (1999) 149-156
65. Redekop W.K., Koopmanschap M.A., Stolk R.P., Rutten G.E., Wolffenbuttel B.H., and Niessen L.W. Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Diabetes Care 25 (2002) 458-463
66. van Agthoven M., Fokkens W.J., van de Merwe J.P., Marijke van Bolhuis E., Uyl de Groot C.A., and Busschbach J.J. Quality of life of patients with refractory chronic rhinosinusitis: effects of filgrastim treatment. Am J Rhinol 15 (2001) 231-237
67. Hilker R., Schischniaschvili M., Ghaemi M., Jacobs A., and Rudolf J. Health related quality of life is improved by botulinum neurotoxin type A in long term treated patients with focal dystonia. J Neurol Neurosurg Psychiatry 71 (2001) 193-199
68. van Agthoven M., Vellenga E., Fibbe W.E., Kingma T., and Uyl de Groot C.A. Cost analysis and quality of life assessment comparing patients undergoing autologous peripheral blood stem cell transplantation or autologous bone marrow transplantation for refractory or relapsed non-Hodgkin's lymphoma or Hodgkin's disease. a prospective randomised trial. Eur J Cancer 37 (2001) 1781-1789
69. Johnson J.A., Connolly M., Zuberbuhler P., and Brown N.E. Health-related quality of life for adults with cystic fibrosis: a regression approach to assessing the impact of recombinant human DNase. Pharmacotherapy 20 (2000) 1167-1174
70. Schrag A., Jahanshahi M., and Quinn N. How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population. Mov Disord 15 (2000) 1112-1118
71. Trueman P., Hood S.C., Nayak U.S., and Mrazek M.F. Prevalence of lower urinary tract symptoms and self-reported diagnosed "benign prostatic hyperplasia," and their effect on quality of life in a community-based survey of men in the UK. BJU Int 83 (1999) 410-415
72. Dolan P., Torgerson D., and Kakarlapudi T.K. Health-related quality of life of Colles' fracture patients. Osteoporos Int 9 (1999) 196-199
73. Brazier J.E., Harper R., Munro J., Walters S.J., and Snaith M.L. Generic and condition-specific outcome measures for people with osteoarthritis of the knee. Rheumatology 38 (1999) 870-877
74. Bryan S., Ratcliffe J., Neuberger J.M., Burroughs A.K., Gunson B.K., and Buxton M.J. Health-related quality of life following liver transplantation. Qual Life Res 7 (1998) 115-120
75. Jenkinson C., Stradling J., and Petersen S. How should we evaluate health status? A comparison of three methods in patients presenting with obstructive sleep apnoea. Qual Life Res 7 (1998) 95-100
76. Richards D.M., and Irving M.H. Assessing the quality of life of patients with intestinal failure on home parenteral nutrition. Gut 40 (1997) 218-222
77. Hurst N.P., Kind P., Ruta D., Hunter M., and Stubbings A. Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D). Br J Rheumatol 36 (1997) 551-559
78. Tidermark J., Zethraeus N., Svensson O., Tornkvist H., and Ponzer S. Femoral neck fractures in the elderly: functional outcome and quality of life according to EuroQol. Qual Life Res 11 (2002) 473-481
79. Jansen A.J., Essink Bot M.L., Beckers E.A., Hop W.C., Schipperus M.R., and Van Rhenen D.J. Quality of life measurement in patients with transfusion-dependent myelodysplastic syndromes. Br J Haematol 121 (2003) 270-274
80. Kind P., Dolan P., Gudex C., and Williams A. Variations in population health status: results from a United Kingdom national questionnaire survey. BMJ 316 (1998) 736-741
81. van der Donk J., Levendag P.C., Kuijpers A.J., Roest F.H., Habbema J.D., Meeuwis C.A., et al. Patient participation in clinical decision-making for treatment of T3 laryngeal cancer: a comparison of state and process utilities. J Clin Oncol 13 (1995) 2369-2378
82. Clarke A.E., Goldstein M.K., Michelson D., Garber A.M., and Lenert L.A. The effect of assessment method and respondent population on utilities elicited for Gaucher disease. Qual Life Res 6 (1997) 169-184
83. Trakas K., Oh P.I., Singh S., Risebrough N., and Shear N.H. The health status of obese individuals in Canada. Int J Obes Relat Metab Disord 25 (2001) 662-668
84. Lawrence W.F., Fryback D.G., Martin P.A., Klein R., and Klein B.E. Health status and hypertension: a population-based study. J Clin Epidemiol 49 (1996) 1239-1245
85. Kaplan R.M., Anderson J.P., Patterson T.L., McCutchan J.A., Weinrich J.D., Heaton R.K., et al. Validity of the Quality of Well-Being Scale for persons with human immunodeficiency virus infection. HNRC Group. HIV Neurobehavioral Research Center. Psychosom Med 57 (1995) 138-147
86. Ratcliffe J., Longworth L., Young T., Bryan S., Burroughs A., and Buxton M. Assessing health-related quality of life pre- and post-liver transplantation: a prospective multicenter study. Liver Transplant 8 (2002) 263-270
87. Lalonde L., Clarke A.E., Joseph L., Mackenzie T., and Grover S.A. Health-related quality of life with coronary heart disease prevention and treatment. J Clin Epidemiol 54 (2001) 1011-1018
88. Lalonde L., Clarke A.E., Joseph L., Mackenzie T., and Grover S.A. Comparing the psychometric properties of preference-based and nonpreference-based health-related quality of life in coronary heart disease. Canadian Collaborative Cardiac Assessment Group. Qual Life Res 8 (1999) 399-409
89. Tosteson A.N., Gabriel S.E., Kneeland T.S., Moncur M.M., Manganiello P.D., Schiff I., et al. Has the impact of hormone replacement therapy on health-related quality of life been undervalued?. J Womens Health Gend Based Med 9 (2000) 119-130
90. Miners A.H., Sabin C.A., Mocroft A., Youle M., Fisher M., and Johnson M. Health-related quality of life in individuals infected with HIV in the era of HAART. HIV Clin Trials 2 (2001) 484-492
91. Van Cleemput P., and Parry G. Health status of Gypsy Travellers. J Public Health Med 23 (2001) 129-134
92. Suarez Almazor M.E., and Conner Spady B. Rating of arthritis health states by patients, physicians, and the general public. Implications for cost-utility analyses. J Rheumatol 28 (2001) 648-656
93. Schneider S.M., Pouget I., Staccini P., Rampal P., and Hebuterne X. Quality of life in long-term home enteral nutrition patients. Clin Nutr 19 (2000) 23-28
94. Badia X., Herdman M., and Kind P. The influence of ill-health experience on the valuation of health. Pharmacoeconomics 13 (1998) 687-696
95. Gudex C.M., Hawthorne M.R., Butler A.G., and Duffey P. Effect of dystonia and botulinum toxin treatment on health-related quality of life. Mov Disord 13 (1998) 941-946
96. Badia X., Diaz Prieto A., Rue M., and Patrick D.L. Measuring health and health state preferences among critically ill patients. Intensive Care Med 22 (1996) 1379-1384
97. Essink Bot M.L., van Royen L., Krabbe P., Bonsel G.J., and Rutten F.F. The impact of migraine on health status. Headache 35 (1995) 200-206
98. Fryback D.G., Dasbach E.J., Klein R., Klein B.E., Dorn N., Peterson K., et al. The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors. Med Decis Making 13 (1993) 89-102
99. Patrick D.L., Starks H.E., Cain K.C., Uhlmann R.F., and Pearlman R.A. Measuring preferences for health states worse than death. Med Decis Making 14 (1994) 9-18
100. Badia X., Fernandez E., and Segura A. Influence of socio-demographic and health status variables on evaluation of health states in a Spanish population. Eur J Public Health 5 (1995) 87-93
101. Terwee C., Wakelkamp I., Tan S., Dekker F., Prummel M.F., and Wiersinga W. Long-term effects of Graves' ophthalmopathy on health-related quality of life. Eur J Endocrinol 146 (2002) 751-757
102. Miners A.H., Holmes A., Sherr L., Jenkinson C., and MacDermot K.D. Assessment of health-related quality-of-life in males with Anderson Fabry Disease before therapeutic intervention. Qual Life Res 11 (2002) 127-133
103. Collins E.D., Kerrigan C.L., Kim M., Lowery J.C., Striplin D.T., Cunningham B., et al. The effectiveness of surgical and nonsurgical interventions in relieving the symptoms of macromastia. Plast Reconstr Surg 109 (2002) 1556-1566
104. Groessl E.J., Kaplan R.M., Barrett Connor E., and Ganiats T.G. Body mass index and quality of well-being in a community of older adults. Am J Prev Med 26 (2004) 126-129
105. Stein M.B., and Kean Y.M. Disability and quality of life in social phobia: epidemiologic findings. Am J Psychol 157 (2000) 1606-1613
106. Unutzer J., Patrick D.L., Diehr P., Simaon G., Grembowski D., and Katon W. Quality adjusted life years in older adults with depressive symptoms and chronic medical disorders. Int Psychogeriatr 12 (2000) 15-33
107. Kaplan R.M., Schmidt S.M., and Cronan T.A. Quality of well being in patients with fibromyalgia. J Rheumatol 27 (2000) 785-789
108. Brown J., Kapow J., Doleys D., Lowery D., and Tutak U. Disease-specific and generic health outcomes: a model for the evaluation of long-term intrathecal opioid therapy in noncancer low back pain patients. Clin J Pain 15 (1999) 122-131
109. Holbrook T.L., Anderson J.P., Sieber W.J., Browner D., and Hoyt D.B. Outcome after major trauma: 12-month and 18-month follow-up results from the Trauma Recovery Project. J Trauma 46 (1999) 765-771
110. Williams R.A., Brody B.L., Thomas R.G., Kaplan R.M., and Brown S.I. The psychosocial impact of macular degeneration. Arch Ophthalmol 116 (1998) 514-520
111. Egger M., Davey Smith G., Schneider M., and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997) 629-634
112. Corporation S. StataCorp Stata Statistical Software. Release 6.0 ed (1999), Stata Corporation, College Station, TX
113. Berkey C.S., Hoaglin D.C., Mosteller F., and Colditz G.A. A random-effects regression model for meta-analysis. Stat Med 14 (1995) 395-411
114. Hauck W.W., Anderson S., and Marcus S.M. Should we adjust for covariates in nonlinear regression analyses of randomized trials?. Control Clin Trials 19 (1998) 249-256
115. Higgins J., Thompson S., Deeks J., and Altman D. Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice. J Health Serv Res Policy 7 (2002) 51-61
116. Adang E.M., Kootstra G., Baeten C.G., and Engel G.L. Quality-of-life ratings in patients with chronic illnesses. JAMA 277 (1997) 1038
117. Postulart D., and Adang E.M. Response shift and adaptation in chronically ill patients. Med Decis Making 20 (2000) 186-193
118. Badia X., Garcia Losa M., Dal Re R., Carballido J., and Serra M. Validation of a harmonized Spanish version of the IPSS: evidence of equivalence with the original American scale. International Prostate Symptom Score. Urology 52 (1998) 614-620